Search results
Results from the WOW.Com Content Network
Liver diseases, including conditions such as non-alcoholic fatty liver disease (NAFLD), alcohol-related liver disease (ALD), and viral hepatitis, are significant public health concerns worldwide. In the United States, NAFLD is the most common chronic liver condition, affecting approximately 24% of the population, with the prevalence rising due ...
Chronic liver diseases like chronic hepatitis, chronic alcohol abuse or chronic toxic liver disease may cause liver failure and hepatorenal syndrome; fibrosis and cirrhosis of liver; Cirrhosis may also occur in primary biliary cirrhosis. Rarely, cirrhosis is congenital.
This category reflects the organization of International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Generally, diseases outlined within the ICD-10 codes K70-K77 within Chapter XI: Diseases of the digestive system should be included in this category.
The list of conditions associated with chronic liver disease is extensive and can be categorised in the following way: [3]. Viral causes. Hepatitis B; Hepatitis C; Cytomegalovirus (CMV), Epstein Barr virus (EBV), and yellow fever viruses cause acute hepatitis.
Alcoholic fatty liver disease. This is also known as alcoholic steatohepatitis. It’s caused by heavy alcohol consumption. It’s possible to have both types of fatty liver disease at the same time.
The disease is so metabolically driven that the American Association for the Study of Liver Disease recently created a subclass of NAFLD called metabolic dysfunction-associated steatosis liver ...
Liver diseases may be diagnosed by liver function tests–blood tests that can identify various markers. For example, acute-phase reactants are produced by the liver in response to injury or inflammation. The most common chronic liver disease is nonalcoholic fatty liver disease, which affects an estimated one-third of the world population. [59 ...
It's a very impressive organ, says Meena B. Bansal, M.D., professor of medicine, and director of translational research in liver diseases at the Icahn School of Medicine at Mount Sinai.